Symbol: |
BCAS2
|
Description: |
breast carcinoma amplified sequence 2 [Source:HGNC Symbol;Acc:975]
|
Location: |
Chr1:115110178-115124260[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:145
Gene |
Compound |
Gen_sig |
Exp_pattern |
BCAS2 |
5,5'-bis(2-methyl-1H-indol-3-yl)-3,3'-biisoxazole |
0.038 |
Up |
BCAS2 |
MYCOTRIENINE-LIKE |
0.012 |
Down |
BCAS2 |
Myricitin |
0.035 |
Down |
BCAS2 |
FCDR |
0.029 |
Down |
BCAS2 |
NSC 607281 |
0.046 |
Down |
BCAS2 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.031 |
Down |
BCAS2 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.016 |
Down |
BCAS2 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.014 |
Down |
BCAS2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride |
0.03 |
Down |
BCAS2 |
9-AMINO-20-CAMPTOTHECIN |
0.04 |
Down |
BCAS2 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.032 |
Down |
BCAS2 |
NSC 633912 |
0.031 |
Down |
BCAS2 |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.021 |
Down |
BCAS2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride |
0.013 |
Down |
BCAS2 |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.01 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:5
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:27
Total:2 Current:1
[First] [Prev]  Next Last 
|